Attention deficit hyperactivity disorder
A child named Leo sits in a classroom, his pencil tapping rhythmically against the desk while his eyes drift toward the window. He has not finished writing his name on the paper yet, and the teacher's voice fades into background noise. This scene illustrates the core symptom of inattention that defines attention deficit hyperactivity disorder. The Diagnostic and Statistical Manual of Mental Disorders fifth edition requires at least six symptoms for children under 17 to establish this diagnosis. These symptoms must persist for six months or more and appear in multiple settings like home and school. A teenager named Maya might display five symptoms instead if she is over 17 years old. Her struggles include losing items, forgetting daily activities, and appearing lost in thought during conversations. Hyperactivity manifests differently across ages as well. Young children often run around or climb in inappropriate situations. Adults experience this as inner restlessness or an inability to relax. Impulsivity appears as interrupting others, blurting out answers, or making decisions without considering consequences. Emotional dysregulation remains a common but unofficial symptom affecting mood stability. Social rejection occurs in about half of all children with ADHD compared to 10 to 15 percent of their peers. Girls tend to show fewer hyperactive symptoms but more inattentive ones. Boys frequently present with externalizing behaviors while girls internalize their struggles.
Twin studies reveal that genetics account for 70 to 80 percent of ADHD variance. This high heritability rate suggests that family history plays a massive role in determining risk. Siblings of children with ADHD are three to four times more likely to develop the disorder than siblings of those without it. Environmental factors exert their effects very early in life during the prenatal or postnatal period. Lead exposure increases the likelihood of developing ADHD-like problems. Children exposed to polychlorinated biphenyls face similar risks from toxic substances. Alcohol intake during pregnancy can cause fetal alcohol spectrum disorders including ADHD symptoms. Extreme premature birth and very low birth weight also elevate risk levels significantly. Infections like measles or rubella during pregnancy contribute to developmental disruptions. At least 30 percent of children who suffer traumatic brain injuries later develop ADHD. About 5 percent of cases stem directly from brain damage rather than genetic inheritance. Maternal smoking associations disappear after adjusting for family history indicating genetic confounding. Artificial food dyes may increase prevalence in sensitive children though evidence remains weak. The European Union has implemented regulatory measures based on these concerns. Natural selection has acted against genetic variants for over 45,000 years complicating evolutionary theories. A common variant of latrophilin 3 accounts for roughly 9 percent of all cases globally.
Brain imaging studies show reduced volume in the left prefrontal cortex among individuals with ADHD. Structural MRI scans reveal thinner posterior parietal cortex compared to control groups. Subcortical volumes including the accumbens amygdala caudate hippocampus and putamen appear smaller in affected populations. Functional connectivity between subcortical and cortical regions shows higher hyperconnectivity correlating with symptom severity. Dopamine pathways originating in the ventral tegmental area project to diverse brain regions governing cognitive processes. Norepinephrine systems arising from the locus coeruleus modulate executive function motivation reward perception and motor function. Elevated numbers of dopamine transporters were once thought central but now appear adaptive following stimulant exposure. Current models emphasize mesocorticolimbic dopamine pathways alongside noradrenergic systems. PET mapping indicates mu-opioid receptor distribution contributes most strongly to cortical abnormalities followed by CB1 cannabinoid receptors. White matter differences show marked inter-hemispheric asymmetry between ADHD and typically developing youths. Hemispheric lateralization processes remain postulated yet empirical results contradict consistent findings. Executive functions such as attentional control inhibitory control and working memory suffer core deficits. These impairments result in problems staying organized keeping time controlling procrastination maintaining concentration ignoring distractions regulating emotions and remembering details.
Diagnosis relies on behavioral assessments rather than biological tests according to current standards. The Achenbach System of Empirically Based Assessment includes parent teacher and self-report forms for evaluation. Child Behavior Checklist rates parental observations while Youth Self Report Form captures children's own perspectives. Teacher Report Forms provide classroom context crucial for accurate diagnosis. Rating scales like Vanderbilt ADHD diagnostic scale allow multiple informants to contribute data. Reliability between raters ranges from poor to moderate requiring information from several sources. Brain imaging studies do not give consistent results thus remaining research tools only. Electroencephalography lacks sufficient accuracy for clinical diagnosis purposes alone. International Classification of Diseases code 6A05 classifies the disorder globally outside North America. DSM-5 criteria dominate usage in United States and Australia regions specifically. European countries usually apply ICD-11 guidelines instead. Diagnostic accuracy depends heavily on comparison groups whether distinguishing from peers or clinically referred youth. About half of diagnostic studies evaluate clinical samples defined as children undergoing workups for potential conditions. Children younger than seven years receive very few dedicated studies with insufficient evidence strength available. CBCL and Disruptive Behavior Diagnostic Observation Schedule showed good performance metrics overall. BRIEF worked exceptionally well within tested parameters despite limited age-specific data.
Medications including methylphenidate and amphetamine derivatives serve as first-line treatments for most patients. Approximately 70 percent respond positively to their initial stimulant choice. Only about 10 percent fail to respond to either amphetamines or methylphenidate entirely. Behavioral therapies remain recommended first-line options for preschool-aged children or those with mild symptoms. Cognitive behavioral therapy helps address residual problems after medication optimization occurs successfully. Neurofeedback demonstrates greater treatment effects than non-active controls lasting up to six months potentially extending a year longer. Akili Interactive Labs developed EndeavourRx becoming the first game-based therapeutic granted FDA marketing authorization in 2020. Pediatric STARS-ADHD trials showed significant improvement in attention measures after four weeks of home use. Adults participating in subsequent studies demonstrated nearly seven times greater magnitude improvements compared to pediatric trials. Atomoxetine offers an alternative non-stimulant option approved by regulatory bodies worldwide. Viloxazine shows comparable efficacy to atomoxetine and methylphenidate with fewer side effects reported consistently. Long-term safety reviews indicate no statistically significant association between ADHD medications and cardiovascular disease risks across all age groups. Stimulants reduce unintentional injury risks significantly while improving persistence task performance academic achievement and reducing substance abuse rates. Side effects like insomnia occur between 11 and 45 percent depending on specific medication chosen.
About 15 percent of children diagnosed with ADHD continue meeting full criteria at age 25 years old. Fifty percent still experience some symptoms into adulthood despite reduced hyperactivity levels. Worldwide estimates suggest 2.58 percent of adults have persistent ADHD while 6.76 percent show symptomatic presentations. In 2020 this translated to roughly 139 million people with persistent forms and over 366 million with symptomatic versions. Many adults remain untreated leading to disorganized lives and increased reliance on non-prescribed drugs or alcohol. Relationship difficulties job instability criminal activity risks increase substantially without proper intervention. Anxiety disorders affect the population more commonly than mood disorders though both frequently co-occur. Bipolar disorder requires careful assessment due to overlapping symptoms creating diagnostic complexity. Suicide risk increases significantly across all age groups according to systematic reviews published in 2017 and 2020. Prevalence of suicide attempts reaches 18.9 percent among individuals with ADHD compared to 9.3 percent without it. Rejection sensitive dysphoria affects a majority of people experiencing deep anxiety humiliation at slightest rebuffs. Bullying connects strongly to later sensitivity issues stemming from peer rejection experiences. Eating disorders occur three times more often in ADHD populations while those with eating disorders are twice as likely to have ADHD. Sleep problems including insomnia restless legs syndrome delayed phase disorder complicate daily functioning further.
Continue Browsing
Common questions
What are the core symptoms of attention deficit hyperactivity disorder in children?
The core symptom of attention deficit hyperactivity disorder is inattention, which requires at least six symptoms for children under 17 to establish a diagnosis. These symptoms must persist for six months or more and appear in multiple settings like home and school.
How much does genetics contribute to the risk of developing attention deficit hyperactivity disorder?
Genetics account for 70 to 80 percent of attention deficit hyperactivity disorder variance according to twin studies. Siblings of children with attention deficit hyperactivity disorder are three to four times more likely to develop the disorder than siblings of those without it.
Which brain regions show structural differences in individuals with attention deficit hyperactivity disorder?
Brain imaging studies show reduced volume in the left prefrontal cortex among individuals with attention deficit hyperactivity disorder. Structural MRI scans reveal thinner posterior parietal cortex compared to control groups along with smaller subcortical volumes including the accumbens amygdala caudate hippocampus and putamen.
What medications are considered first-line treatments for attention deficit hyperactivity disorder?
Medications including methylphenidate and amphetamine derivatives serve as first-line treatments for most patients with attention deficit hyperactivity disorder. Approximately 70 percent respond positively to their initial stimulant choice while only about 10 percent fail to respond to either amphetamines or methylphenidate entirely.
What percentage of adults diagnosed with attention deficit hyperactivity disorder continue meeting full criteria at age 25 years old?
About 15 percent of children diagnosed with attention deficit hyperactivity disorder continue meeting full criteria at age 25 years old. Worldwide estimates suggest 2.58 percent of adults have persistent forms and over 366 million people show symptomatic versions globally.